Speaking Engagements
Healthcare Securities Class Actions, SEC Enforcement & Emerging Capital Markets Risks
September 2, 2026
In a recent decision, the Delaware Court of Chancery held on summary judgment that a borrower’s grant of a security interest in substantially all of its assets, including its rights under a license agreement, constituted an “assignment” or “transfer” of such rights that triggered the license agreement counterparty’s contractual right of first negotiation (ROFN) and right of first refusal (ROFR). The decision has implications beyond the pharmaceutical licensing context in which it arose, and should prompt careful review of transfer restriction provisions in any agreement where a party may later seek to pledge its contractual rights as collateral.
Background
Two businesses were parties to a license agreement under which the licensee held the exclusive right to develop and commercialize certain pharmaceutical products. Section 15.5(c) of the license agreement restricted the licensor from making a “payment assignment,” defined to include any decision to “sell, assign, contribute, convey, grant or otherwise transfer to any Third Party” all or any of the licensor’s rights to receive payment under the agreement, without first providing the licensee with written notice and complying with a 30-day right of first negotiation and a subsequent right of first refusal to match the terms of any third-party transaction.
In 2024, the licensor entered into a credit agreement with third-party lenders, granting them a first-priority perfected lien on, and security interest in, substantially all of its assets, including all license agreements. The licensor failed to notify the licensee or comply with the ROFN/ROFR procedures before executing the credit agreement. The licensee sued, alleging the licensor breached Section 15.5(c).
Holding
The court granted summary judgment to the licensee on liability. The court’s analysis rested on two complementary grounds.
First, the court held that the grant of a security interest fell within the contractual definition of payment assignment because the license agreement’s transfer restriction was not limited to outright sales or assignments. The catchall language (or otherwise transfer) was broad enough to encompass the creation of a lien. The court relied on the ordinary meaning of “transfer,” which includes parting with an interest in an asset, such as the creation of a lien or other encumbrance. The court reasoned that by pledging all license agreements as collateral, the licensor necessarily transferred an interest in the payment rights arising from those contracts.
Second, and critically, the court found structural confirmation in the license agreement itself. Section 15.5(c) specifically carved out a prior collateral assignment to a lender from the definition of payment assignment. Applying the canon of expressio unius est exclusio alterius,[1] the court reasoned that the parties’ decision to exclude one specific collateral assignment implied that other collateral assignments were included within the general rule. If security interests were categorically outside the scope of the transfer restriction, the prior lender carve-out would be surplusage.
The Court Rejected Four Defenses
The licensor raised four legal defenses, each of which the court rejected:
Takeaways for Financing Transactions
This decision has direct implications for borrowers, lenders, and counterparties to agreements containing transfer restrictions:
[1] Meaning, “one thing is the exclusion of the other.”
This just in
Speaking Engagements
Healthcare Securities Class Actions, SEC Enforcement & Emerging Capital Markets Risks
September 2, 2026
Speaking Engagements
PFAS for Decision Makers: Managing PFAS Risk in Today’s Deals – While Preparing for What’s Next
August 27, 2026 | 12:00 PM – 1:00 PM CT
Webinar
Firm Events
Cocktails and Networking During MEDevice Boston
August 26, 2026 | 6:00 PM – 8:00 PM ET
Lifted Restaurant
450 Summer St, Boston, MA 02210
Speaking Engagements
The 2026 Multifamily Maturity Cliff: Reading the $162 Billion Refinancing Wave and the Engagements It Will Generate
August 26, 2026 | 1:00 PM – 3:10 PM ET
Webinar